Huma wins prestigious Prix Galien USA 2021 award

Huma’s remote patient monitoring technology is awarded ‘pharma’s Nobel Prize’

Huma Therapeutics has won the inaugural Prix Galien award for Digital Health, regarded as ‘the equivalent of the Nobel Prize in biopharmaceutical research’.

The announcement was made at the award ceremony in New York on Thursday night, following decisions from a judging panel that included past and present CEOs and Global Heads of GSK, Johnson & Johnson, Pfizer, Roche, Sanofi and Bill & Melinda Gates Medical Research Institute.

Dr. Sue Desmond-Hellmann, Chair of the Prix Galien USA and Prix Galien International Award Committees and former CEO of the Bill & Melinda Gates Foundation, said: “On behalf of the Prix Galien USA Awards Committee, we want to thank all nominees and winners for their dedication to advancing human life. Their tireless dedication to research, development and innovation has been critical in improving health and wellness of countless individuals around the world.”

https://huma.com/thoughtpiece/prixgalienaward